Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Emergent BioSolutions Inc. Common Stock (NY: EBS )

11.35 +0.24 (+2.12%)
Streaming Delayed Price Updated: 10:42 AM EST, Jan 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 182,255
Open 11.25
Bid (Size) 11.32 (3)
Ask (Size) 11.37 (1)
Prev. Close 11.11
Today's Range 11.10 - 11.51
52wk Range 1.420 - 15.10
Shares Outstanding 54,100,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
The Analyst Verdict: Emergent BioSolutions In The Eyes Of 4 Experts
Via Benzinga
Enrollment Starts in Africa CDC-Led MpOx Therapeutic Study (MOSA)
From Emergent BioSolutions
Via GlobeNewswire

Performance

YTD
+10.47%
+10.47%
1 Month
+18.67%
+18.67%
3 Month
+25.22%
+25.22%
6 Month
+7.33%
+7.33%
1 Year
+579.34%
+579.34%

More News

Read More
Emergent BioSolutions Gains Exclusive Commercial Rights to KLOXXADO® (naloxone HCI) Nasal Spray from Hikma Pharmaceuticals
From Emergent BioSolutions
Via GlobeNewswire
Emergent BioSolutions Receives Contract Option Valued at Approximately $16.7 Million to Continue Development Collaboration with BARDA on Ebanga™ (ansuvimab-zykl) Treatment for Ebola
From Emergent BioSolutions
Via GlobeNewswire
Emergent BioSolutions to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025
From Emergent BioSolutions
Via GlobeNewswire
Emergent BioSolutions Announces Exercise of $20 Million Option to Supply U.S. Department of Defense with BioThrax® (Anthrax Vaccine Adsorbed)
From Emergent BioSolutions
Via GlobeNewswire
Why Emergent BioSolutions Stock Blasted Higher Today
Via The Motley Fool
Nasdaq Down Over 100 Points; US Pending Home Sales Increase In November
Via Benzinga
Crude Oil Gains 1%; Chicago PMI Falls In December
Via Benzinga
Exposures Fossil Fuels
Cytek Biosciences, Emergent BioSolutions, Radiopharm Theranostics And Other Big Stocks Moving Higher On Monday
Via Benzinga
This Nuvalent Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Via Benzinga
Emergent BioSolutions Receives $50 Million Contract Option from BARDA to Procure Doses of CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted)
From Emergent BioSolutions
Via GlobeNewswire
War On Drugs 'Has Failed, Completely And Utterly': UN High Commissioner Urges Evidence-Based Solutions
Via Benzinga
Why Emergent BioSciences Stock Plummeted Today
Via The Motley Fool
Emergent's Vaccine Production Failure: Contamination Scandal, Investor Backlash, and $40M Settlement
Via Benzinga
From GLD To TSLA: Unlocking Today’s Best Trading Opportunities
Via Talk Markets
Topics Stocks / Equities
After Trump's Win, It's Time To Take Profits On Gold
Via Benzinga
Topics Government
Exposures Political
Overdose Crisis In Shadows Of Elections As Black, Indigenous Americans Deaths Rise
Via Benzinga
Topics Death
Exposures Death
Mpox Vaccine Player Emergent BioSolutions Stock Jumps On Upbeat Annual Forecast, Expects Smaller Losses In 2024
Via Benzinga
Crude Oil Rises 1%; US Jobless Claims Increase To 221,000
Via Benzinga
Exposures Fossil Fuels
Gold Gains 1%; Halliburton Posts Weak Q3 Results
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
HubSpot Posts Better-Than-Expected Results, Joins Under Armour, Lyft, Wolverine World Wide, Zillow And Other Big Stocks Moving Higher On Thursday
Via Benzinga
The Post-Trump Victory Trade
Via Benzinga
Topics Government
Exposures Political
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.